CD274 and diffuse large B-cell lymphoma: Likewise, another study reported that DLBCL with PD-L1 alterations experienced an inferior PFS following front-line chemoimmunotherapy; however, the in relapsed setting, PD-L1 alterations were associated with a response to anti-PD-1 antibodies [82].